Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Atara, Camurus, Encoded, Eureka, Fabentech, Novita, Sanofi, Sebela, Summit.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alivecor, Innovative Health, Teoxane, Vy Spine.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Arrowhead Pharmaceutical, Ark Biopharmaceutical, GSK, Kelun-Biotech, Scinopharm, Takeda, Vivavision, Zai Lab.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alessa, Aquestive, Kezar, PDS, Uniqure.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medtronic, Neurolief, Oxford Nanopore.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: 858, Annexon, Arbele, Complement, Intent, Invivyd, Moonlake, Plus, Revolution, RVL, Vanda, Vectory.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Siemens Healthineers.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Akeso, Arrowhead, Curadel, GSK, Vivavision.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accukardia, Cmr Surgical, Reflexion Medical, Saluda Medical, Sky Labs, Xenex.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Alkermes, Ark, Bioarctic, Biogen, Biosplice, Cellenkos, Eisai, GSK, Johnson & Johnson, Milestone, Oculis, Zai Lab.